About: Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.39 (+3.04%)
CAMP NASDAQ CAMP4 THERAPEUTICS CORPORATION
CAMP4 THERAPEUTICS CORPORATION share price
Atividade de preço de CAMP
Último preço
$ 3,390
Variação (24h)
0,10 USD (3,04%)
Volume
141.12K
Volume (média 4 sem.)
-
Abertura
$ 3,20
Variação do dia
$ 3,17 - $ 3,49
Fechamento anterior
$ 3,29
Último negócio
22 Oct, 8:00 pm GMT+0
Atrasado
22 Oct, 8:00 pm GMT+0
CAMP price performance
Atrasado
22 Oct, 8:00 pm GMT+0
quote.marketSignals